REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF THE COUNTY OF SAN BERNARDINO
AND RECORD OF ACTION
May 18, 2021
FROM
WILLIAM L. GILBERT, Director, Arrowhead Regional Medical Center
SUBJECT
Title v
Rider to the Agreement with Praxair Distribution Inc. for the Provision of INOtherapy Services
End
RECOMMENDATION(S)
Recommendation
Approve the Rider to Product Supply Agreement No. 21-302 with Praxair Distribution Inc. for the provision of INOtherapy services, extending the contract period to May 17, 2024, for a total contract period of August 22, 2017 through May 17, 2024, with no change to the not to exceed amount of $1,930,000.
(Presenter: William L. Gilbert, Director, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Operate in a Fiscally-Responsible and Business-Like Manner.
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item with Praxair Distribution Inc. (Praxair) will not result in the use of Discretionary General Funding (Net County Costs). There are no costs associated with this additional provision to the agreement. Sufficient appropriation for the agreement has been included in the Arrowhead Regional Medical Center (ARMC) 2020-21 budget and will be included in future recommended budgets.
BACKGROUND INFORMATION
Approval of this item will allow ARMC to receive INOtherapy services from Praxair, which consists of the pharmaceutical drug Noxivent (nitric oxide) for inhalation and the delivery devices needed to administer the drug. The INOtherapy services will be used at the Neonatal Intensive Care Unit (NICU) at ARMC. Inhaled nitric oxide is a specific pulmonary medication that dilate blood vessels. It affects the muscles in the walls of the arteries and veins, preventing the muscles from tightening and the walls from narrowing. As a result, blood flows more easily through the vessels, reducing blood pressure and increasing oxygen supplies in the...
Click here for full text